Sign in

Oscar R Durón

@osduvar.bsky.social
622 followers 514 following 29 posts

Nephrologist. Enthusiast about all things Nephrology. NPATH fellow 2021-2023. NephEdC Internship 2024.

PostsRepliesMedia
Oscar R Durón @osduvar.bsky.social · 30/11/2025
👏🏼
000
Reposted by Oscar R Durón
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 21/10/2025
The latest empadata dump: @nephroseeker.medsky.social writes up a #NephJC short on the meta analysis www.nephjc.com/news/2025/10...
nephjc.com
Empagliflozin, the kidney, and what we still don’t understand — NephJC
NephJC short on an empagliflozin meta-analysis
12415
Oscar R Durón @osduvar.bsky.social · 21/06/2025
Congratulations to all the Interns of this new program! Looking forward to follow their journey.
030
Oscar R Durón @osduvar.bsky.social · 10/05/2025
Legends!
010
Reposted by Oscar R Durón
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 25/04/2025
A one year delay in diagnosis of #hypertension! Clear illustration of the importance of measuring BP in both arms www.ahajournals.org/doi/10.1161/... in @ahajournals.bsky.social Hypertension
Table. Timeline of Clinic Visits and Blood Pressure MeasurementsFigure. Computed tomography angiography (CTA) of subclavian artery stenosis. Axial CTA image of this patient with subclavian artery stenosis. A, Patent subclavian artery (indicated by the arrow) distal to the site of the occlusion. B, A more inferior axial image with an absence of contrast in the subclavian artery at the level of the subtotal occlusion while (C) demonstrates the most inferior and proximal to the aortic arch and re-demonstrates a patent proximal portion of the subclavian artery. This is consistent with a subtotal occlusion of the subclavian artery with distal reconstitution likely via the left vertebral artery
13210
Oscar R Durón @osduvar.bsky.social · 17/04/2025
This. 😇
000
Reposted by Oscar R Durón
kireports.bsky.social @kireports.bsky.social · 26/03/2025
Our topic: Use of dapagliflozin (SGLT2 inhibitor) in patients with autosomal dominant polycystic kidney disease (ADPKD) concurrently on tolvaptan therapy. There are no conflicts of interest. #MedSky #NephSky Article: www.kireports.org/article/S2468-0249(25)00048-8/fulltext
kireports.org
Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan
Although dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, delays the progression of chronic kidney disease (CKD), its effect on patients with autosomal dominant polycystic kidney dis...
173
Reposted by Oscar R Durón
Nephrology Journal Club @nephjc.bsky.social · 25/03/2025
Check out the VA from @nephroseeker.medsky.social 👀 Join us tonite at 9pm EST to discuss @kdigo.org ADPKD 2025 guidelines 📚 #NephSky#MedSky #NephJC www.nephjc.com/news/2025/kdigo-adpkd-va
nephjc.com
The first KDIGO ADPKD guideline — NephJC
The KDIGO ADPKD guideline is a result of a decade of global collaboration between physicians, researchers, advocates, and patients. 240 pages summarized in only 2 pictures, made by Cristina Popa .
0136
Reposted by Oscar R Durón
Nephrology Journal Club @nephjc.bsky.social · 12/03/2025
Not lastly, #NephSky #MedSky ✨This year we try something new: #nephjc internship If curious, wanna apply, need to be part of our world-wide community, apply 👇
0147
Reposted by Oscar R Durón
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 19/03/2025
Drugs or devices? For #NephMadness, I make my choice ajkdblog.org/2025/03/19/n... Let’s see if the wise #BlueRibbonFail panel likes similar sensible solutions!
ajkdblog.org
#NephMadness 2025: Renal Denervation in Hypertension: Fad or Fixture?
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025   Swapnil Hiremath Swapnil Hiremath is a Professor at the University of Ottawa and an Associate Scientist at the Otta…
0138
Reposted by Oscar R Durón
American Journal of Kidney Diseases @ajkd.bsky.social · 15/03/2025
Need weekend plans? Catch up on all the #NephMadness 2025 regions: -Resistant Hypertension -Obesity -Green House -Minimal Change Disease -Disaster Nephrology -Genetics -Hemodialysis -CAR-T for Kidney Disease Happy reading! bit.ly/4iMNijV
062
Oscar R Durón @osduvar.bsky.social · 26/02/2025
I order it in resistant hypertension or young patients with hypertension. I admit I have a wonderful endocrinologist team who helps me interpret results and go further with more tests if necessary.
020
Oscar R Durón @osduvar.bsky.social · 20/02/2025
That’s where I am coming from. Thank you for your input on this.
000
Oscar R Durón @osduvar.bsky.social · 20/02/2025
Do this interfere on your decision making? Having proteinuria <1 gr or >2 gr can make a difference in some patients.
100
Oscar R Durón @osduvar.bsky.social · 20/02/2025
That’s a very good point. Thank you.
100
Oscar R Durón @osduvar.bsky.social · 19/02/2025
Thank you very much. Very helpful! 🙆🏽‍♂️
000
Oscar R Durón @osduvar.bsky.social · 19/02/2025
Now that we are in the subject, do you have any specific use for Cr excretion? Do you consider any specific value for “high” and “low” or just go with what your lab parameters?
100
Oscar R Durón @osduvar.bsky.social · 19/02/2025
I’ll take a look. Thank you very much!
000
Oscar R Durón @osduvar.bsky.social · 19/02/2025
BMI > 30 but no hyperflitration in eGFR.
100
Oscar R Durón @osduvar.bsky.social · 19/02/2025
All I found was this study, which concludes that there is a strong correlation between both tests. In my clinical practice, this is not the case. I want to hear everyone’s thought on this. Here to learn! www.revistanefrologia.com/es-pdf-X0211...
revistanefrologia.com
Correlación entre el cociente proteína/creatinina en orina esporádica y las proteínas en orina de 24 horas
010
Oscar R Durón @osduvar.bsky.social · 19/02/2025
A question to all Nephrologists, how do you approach the difference in proteinuria between samples of spot urine and 24 hr urine? In this example: - Spot Urine Alb/Cr ratio: 938 mg/g - 24 hrs: 2,177 mg/24 hrs My calculations for Alb/Cr ratio in 24 hr is 985 mg/g #AskRenal
341
Oscar R Durón @osduvar.bsky.social · 18/12/2024
🤩
000
Reposted by Oscar R Durón
Nephrology Journal Club @nephjc.bsky.social · 17/12/2024
🎨The visual abstract made by @drnikhil.bsky.social #NephSKy #MedSKy, tonight #NephJC goes with an oldie but still goldie topic: RASi in advanced CKD ⏰ Same hour, 9 pm EST www.nephjc.com/news/2024/12...
02011
Oscar R Durón @osduvar.bsky.social · 17/12/2024
Thank you for the insight @jamiekwillows.bsky.social , it definitely spiced up the discussion. And thank you to all the @nephjc.bsky.social team for having my back on this one. I deeply appreciate it and feel flattered to have the opportunity to participate.
040
Reposted by Oscar R Durón
Nephrology Journal Club @nephjc.bsky.social · 17/12/2024
Is it ever too late to start RAS inhibitors in CKD? www.nephjc.com/news/aceing-... from @osduvar.bsky.social Join us this week to discuss on #NephJC
nephjc.com
ACEing the management of advanced CKD — NephJC
This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
2299
Oscar R Durón @osduvar.bsky.social · 17/12/2024
Afraid of RASi on advanced CKD? Should we initiate ACEi and ARBs in stage 4 CKD? Is it safe? Is it worth the risk? Find the answers in this week’s #NephJC blogpost about the most recent meta-analysis on the subject. Spoiler: Keep Calm and Aceit! www.nephjc.com/news/aceing-...
nephjc.com
ACEing the management of advanced CKD — NephJC
This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
040
Oscar R Durón @osduvar.bsky.social · 07/12/2024
This is the way.
010
Oscar R Durón @osduvar.bsky.social · 05/12/2024
Yeah. I would.
000
Oscar R Durón @osduvar.bsky.social · 04/12/2024
I wouldn’t mind doing my Residency again 😅.
110
Oscar R Durón @osduvar.bsky.social · 30/11/2024
Thanks for sharing.
020
Oscar R Durón @osduvar.bsky.social · 29/11/2024
Thank you.
000
Oscar R Durón @osduvar.bsky.social · 28/11/2024
I understood that a solute is or not an effective osmole not because of its ability to permeate a cell membrane but it’s a ability to create a gradient by “dragging water”. Am I wrong about this? Saying urea isn’t an effective osmole is confusing to me, because of desequilibrium syndrome.
220
Oscar R Durón @osduvar.bsky.social · 28/11/2024
Of course. But I meant a gradient caused by Urea in hemodyalisis (chronic patients on their first sessions) and a gradient that occurs for example in a rapid correction of hyponatremia.
000
Oscar R Durón @osduvar.bsky.social · 28/11/2024
So the gradient occurs either way, right? With Sodium and Urea?
100
Oscar R Durón @osduvar.bsky.social · 28/11/2024
I’d like to ask, why do we have disequilibrium syndrome in some patients in hemodyalisis? What does the shift in serum Urea does in the brain? I know it is rare now, but it is still discussed.
100
Oscar R Durón @osduvar.bsky.social · 15/11/2024
Looking forward to it.
000
Oscar R Durón @osduvar.bsky.social · 13/11/2024
Great skytorial. Thank you.
000
Oscar R Durón @osduvar.bsky.social · 13/11/2024
“Inner work is not all ecstatic surrender. Don’t listen too often[…] to the comforting part of the self that gives you what you want. Pray instead for a tough instructor.” - The Essential Rumi
040